Treating depression with ketamine: We need incremental treatment for depression

Recently, the Food and Drug Administration approved a nasal spray version of the drug Ketamine, named Spravato (esketamine), for use as a supplement to oral antidepressants taken by adults living with treatment-resistant depression. The announcement was accompanied by a flurry of media excitement as Spravato is the first medication for depression with a new mechanism […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.

Source: Kevin, M.D. - Medical Weblog - March 25, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/shaili-jain" rel="tag" > Shaili Jain, MD < /a > < /span > Tags: Meds Psychiatry Source Type: blogs